Disposition of 80647 shares by Lee Tillman of Marathon Oil at 26.9411 subject to Rule 16b-3

M Stock   5.88  0.07  1.20%   
About 50% of Med Life's investors are presently thinking to get in. The analysis of current outlook of investing in Med Life SA suggests that some traders are interested regarding Med Life's prospects. Med Life's investing sentiment overview a quick insight into current market opportunities from investing in Med Life SA. Many technical investors use Med Life SA stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Marathon Oil Director, Officer: Chairman, President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 80647 common stock at 26.9411 of Marathon Oil by Lee Tillman on 19th of March 2024. This event was filed by Marathon Oil with SEC on 2024-03-19. Statement of changes in beneficial ownership - SEC Form 4. Lee Tillman currently serves as chairman of the board, president, chief executive officer of Marathon Oil

Peers

Trending Equities

S  0.66   
0%
37.0%
AAL  0.58   
0%
33.0%
WFC  0.24   
0%
13.0%
CVX  0.01   
0%
1.0%
UPS  0.20   
11.0%
0%
T  0.44   
25.0%
0%
C  0.49   
27.0%
0%
HD  0.58   
33.0%
0%
MET  0.60   
34.0%
0%
TGT  0.65   
37.0%
0%
INTC  0.68   
38.0%
0%
IBM  0.94   
53.0%
0%
CVS  0.96   
54.0%
0%
AAPL  1.32   
75.0%
0%
BBY  1.50   
85.0%
0%
AA  1.75   
100.0%
0%

Other Information on Investing in Med Stock

Med Life financial ratios help investors to determine whether Med Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Med with respect to the benefits of owning Med Life security.